Cargando…

Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq

Phosphoenolpyruvate carboxykinase 1 (PCK1), a step limiting enzyme of gluconeogenesis, is downregulated in hepatocellular carcinoma (HCC). Overexpression of PCK1 has been shown to suppress hepatoma cell growth, but the underlying mechanism remains unclear. We used recombinant adenovirus overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Jin, Zhang, Yuhong, Tuo, Lin, Liu, Rui, Gou, Dongmei, Liang, Li, Chen, Chang, Xia, Jie, Tang, Ni, Wang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063442/ https://www.ncbi.nlm.nih.gov/pubmed/32181286 http://dx.doi.org/10.1016/j.gendis.2019.04.004

Ejemplares similares

O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis
por: Liu, Rui, et al.
Publicado: (2021)

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression
por: Gou, Dongmei, et al.
Publicado: (2023)

PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
por: Tuo, Lin, et al.
Publicado: (2018)

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27(Kip1) axis
por: Tuo, Lin, et al.
Publicado: (2019)

NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
por: Tsujimoto, Goki, et al.
Publicado: (2022)

Effect of adeno-associated virus (AAV)-mediated overexpression of PEPCK-M (Pck2) on Clenbuterol-induced muscle growth
por: Loczenski-Brown, David M., et al.
Publicado: (2019)

Comparative transcriptome analysis reveals that PCK1 is a potential gene affecting IMF deposition in buffalo
por: Huang, Jieping, et al.
Publicado: (2020)

Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice
por: Ye, Qian, et al.
Publicado: (2023)

Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency
por: Li, Zheng, et al.
Publicado: (2022)

Emerging roles of cytosolic phosphoenolpyruvate kinase 1 (PCK1) in cancer
por: Abate, Ebsitu, et al.
Publicado: (2023)

Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
por: Liu, Meng-Xi, et al.
Publicado: (2018)

Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease
por: Blazer-Yost, Bonnie L., et al.
Publicado: (2010)

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
por: Ren, Xiang Shan, et al.
Publicado: (2014)

The technique of probing acceptance as a tool for teachers' professional development: A PCK study
por: Wiener, Gerfried J, et al.
Publicado: (2018)

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats
por: Kapoor, Sarika, et al.
Publicado: (2015)

Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
por: Zhao, Jiangsha, et al.
Publicado: (2017)

Self-acetylation at the active site of phosphoenolpyruvate carboxykinase (PCK1) controls enzyme activity
por: Latorre-Muro, Pedro, et al.
Publicado: (2021)

A novel mutation in PCK2 gene causes primary angle-closure glaucoma
por: Xu, Menghan, et al.
Publicado: (2021)

Metformin does not slow cyst growth in the PCK rat model of polycystic kidney disease
por: Oto, Ozgur A., et al.
Publicado: (2023)

SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis
por: Kumar, Amit, et al.
Publicado: (2023)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis
por: Xia, Zongqi, et al.
Publicado: (2010)

c.A2456C-substitution in Pck1 changes the enzyme kinetic and functional properties modifying fat distribution in pigs
por: Latorre, Pedro, et al.
Publicado: (2016)

A transcriptomic study of myogenic differentiation under the overexpression of PPARγ by RNA-Seq
por: He, Kan, et al.
Publicado: (2017)

Androgen Inhibits Abdominal Fat Accumulation and Negatively Regulates the PCK1 Gene in Male Chickens
por: Duan, Jinlin, et al.
Publicado: (2013)

Mitochondrial PCK2 Missense Variant in Shetland Sheepdogs with Paroxysmal Exercise-Induced Dyskinesia (PED)
por: Nessler, Jasmin, et al.
Publicado: (2020)

PURα Promotes the Transcriptional Activation of PCK2 in Esophageal Squamous Cell Carcinoma Cells
por: Sun, Yan, et al.
Publicado: (2020)

PCK1 Deficiency Shortens the Replicative Lifespan of Saccharomyces cerevisiae through Upregulation of PFK1
por: Yuan, Yuan, et al.
Publicado: (2020)

The PCK2-glycolysis axis assists three-dimensional-stiffness maintaining stem cell osteogenesis
por: Li, Zheng, et al.
Publicado: (2022)

Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022)

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Namiki, Toshiki, et al.
Publicado: (2023)

hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
por: Hao, Weijie, et al.
Publicado: (2023)

PCK1 Regulates Glycolysis and Tumor Progression in Clear Cell Renal Cell Carcinoma Through LDHA
por: Shi, Liang, et al.
Publicado: (2020)

T3 and glucose increase expression of phosphoenolpyruvate carboxykinase (PCK1) leading to increased β-cell proliferation
por: Katz, Liora S., et al.
Publicado: (2022)

Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1‐mediated mitochondrial dysfunction
por: Yu, Ze, et al.
Publicado: (2023)

Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
por: Gómez-Valadés, Alicia G., et al.
Publicado: (2008)

Identification of Conserved Regulatory Elements in Mammalian Promoter Regions: A Case Study Using the PCK1 Promoter
por: Liu, George E., et al.
Publicado: (2008)

Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK rats
por: Nagao, Shizuko, et al.
Publicado: (2019)

Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome
por: Narayan, Rithika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7740h4prsklp8bujrk2ma6sgqu